Matches in Wikidata for { <http://www.wikidata.org/entity/Q92137696> ?p ?o ?g. }
- Q92137696 description "2019 nî lūn-bûn" @default.
- Q92137696 description "2019年の論文" @default.
- Q92137696 description "2019年学术文章" @default.
- Q92137696 description "2019年学术文章" @default.
- Q92137696 description "2019年学术文章" @default.
- Q92137696 description "2019年学术文章" @default.
- Q92137696 description "2019年学术文章" @default.
- Q92137696 description "2019年学术文章" @default.
- Q92137696 description "2019年學術文章" @default.
- Q92137696 description "2019年學術文章" @default.
- Q92137696 description "2019年學術文章" @default.
- Q92137696 description "2019年學術文章" @default.
- Q92137696 description "2019年學術文章" @default.
- Q92137696 description "2019년 논문" @default.
- Q92137696 description "article científic" @default.
- Q92137696 description "article scientific" @default.
- Q92137696 description "article scientifique" @default.
- Q92137696 description "articol științific" @default.
- Q92137696 description "articolo scientifico" @default.
- Q92137696 description "artigo científico" @default.
- Q92137696 description "artigo científico" @default.
- Q92137696 description "artigo científico" @default.
- Q92137696 description "artikel ilmiah" @default.
- Q92137696 description "artikull shkencor" @default.
- Q92137696 description "artikulong pang-agham" @default.
- Q92137696 description "artykuł naukowy" @default.
- Q92137696 description "artículo científico publicado en 2019" @default.
- Q92137696 description "artículu científicu" @default.
- Q92137696 description "bilimsel makale" @default.
- Q92137696 description "bài báo khoa học" @default.
- Q92137696 description "naučni članak" @default.
- Q92137696 description "scienca artikolo" @default.
- Q92137696 description "scientific article published on 19 December 2019" @default.
- Q92137696 description "scientific article published on 19 December 2019" @default.
- Q92137696 description "scientific article published on 19 December 2019" @default.
- Q92137696 description "teaduslik artikkel" @default.
- Q92137696 description "tieteellinen artikkeli" @default.
- Q92137696 description "tudományos cikk" @default.
- Q92137696 description "vedecký článok" @default.
- Q92137696 description "vetenskaplig artikel" @default.
- Q92137696 description "videnskabelig artikel udgivet 19. december 2019" @default.
- Q92137696 description "vitenskapelig artikkel" @default.
- Q92137696 description "vitskapeleg artikkel" @default.
- Q92137696 description "vědecký článek" @default.
- Q92137696 description "wetenschappelijk artikel" @default.
- Q92137696 description "wissenschaftlicher Artikel" @default.
- Q92137696 description "επιστημονικό άρθρο" @default.
- Q92137696 description "мақолаи илмӣ" @default.
- Q92137696 description "наукова стаття, опублікована в грудні 2019" @default.
- Q92137696 description "научна статия" @default.
- Q92137696 description "научная статья" @default.
- Q92137696 description "научни чланак" @default.
- Q92137696 description "научни чланак" @default.
- Q92137696 description "מאמר מדעי" @default.
- Q92137696 description "مقالة علمية نشرت في 19 ديسمبر 2019" @default.
- Q92137696 description "১৯ ডিসেম্বর ২০১৯-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
- Q92137696 description "บทความทางวิทยาศาสตร์" @default.
- Q92137696 description "სამეცნიერო სტატია" @default.
- Q92137696 name "Analysis of Japanese patients from the AUGMENT phase III study of lenalidomide + rituximab (R2) vs. rituximab + placebo in relapsed/refractory indolent non-Hodgkin lymphoma" @default.
- Q92137696 name "Analysis of Japanese patients from the AUGMENT phase III study of lenalidomide + rituximab (R2) vs. rituximab + placebo in relapsed/refractory indolent non-Hodgkin lymphoma" @default.
- Q92137696 type Item @default.
- Q92137696 label "Analysis of Japanese patients from the AUGMENT phase III study of lenalidomide + rituximab (R2) vs. rituximab + placebo in relapsed/refractory indolent non-Hodgkin lymphoma" @default.
- Q92137696 label "Analysis of Japanese patients from the AUGMENT phase III study of lenalidomide + rituximab (R2) vs. rituximab + placebo in relapsed/refractory indolent non-Hodgkin lymphoma" @default.
- Q92137696 prefLabel "Analysis of Japanese patients from the AUGMENT phase III study of lenalidomide + rituximab (R2) vs. rituximab + placebo in relapsed/refractory indolent non-Hodgkin lymphoma" @default.
- Q92137696 prefLabel "Analysis of Japanese patients from the AUGMENT phase III study of lenalidomide + rituximab (R2) vs. rituximab + placebo in relapsed/refractory indolent non-Hodgkin lymphoma" @default.
- Q92137696 P1433 Q92137696-5B4BECEA-6579-4066-9EF5-ED71FCF6209B @default.
- Q92137696 P1476 Q92137696-A5E10244-FD16-48EF-8E8C-EB386DB288F5 @default.
- Q92137696 P2093 Q92137696-0E6276BF-D2F7-47BF-82D1-3FCC2E74C62E @default.
- Q92137696 P2093 Q92137696-1ED75D77-C007-4DCA-A035-2A48C2C452AB @default.
- Q92137696 P2093 Q92137696-221A4725-6B63-49E9-9EBB-3C9F3E7B2B1C @default.
- Q92137696 P2093 Q92137696-508B0C6F-3587-4FDA-A8CE-F47CEC978D74 @default.
- Q92137696 P2093 Q92137696-6678138E-52EA-460E-B88B-1C8A727E52CA @default.
- Q92137696 P2093 Q92137696-6ADB9A80-9854-42CE-9587-EF8DC855F6C8 @default.
- Q92137696 P2093 Q92137696-97C8C323-CBD2-44F0-A7FD-7238B81B8CDB @default.
- Q92137696 P2093 Q92137696-A76D6ADB-75BF-4365-A0F9-037FBF180890 @default.
- Q92137696 P2093 Q92137696-BECA188F-68B9-4E7D-BDB5-3093359065D0 @default.
- Q92137696 P2093 Q92137696-C74AE5A7-313A-4A87-81BD-4D587527B23E @default.
- Q92137696 P2093 Q92137696-CA86AFDC-7D24-42DA-A425-B28D37B9E9CB @default.
- Q92137696 P2093 Q92137696-D11503B8-81DC-4BB7-896F-5787251044E5 @default.
- Q92137696 P2093 Q92137696-E0B75F09-78D1-4B6F-8E2D-D651AF7A5702 @default.
- Q92137696 P2093 Q92137696-E18F6044-D8C6-4F18-AB2E-1DD4063367D0 @default.
- Q92137696 P304 Q92137696-4DA363E7-4467-429D-A33C-70C82F0B85E9 @default.
- Q92137696 P31 Q92137696-86DDC95C-4BAC-4844-8B79-E623DCEB404F @default.
- Q92137696 P356 Q92137696-211B1FAA-2DC8-4F23-B542-C2CFD92C53A3 @default.
- Q92137696 P433 Q92137696-D5195D71-7694-450A-86FD-C93111D9C203 @default.
- Q92137696 P478 Q92137696-78E7726E-33F5-491A-94E8-1DAF4FEE2026 @default.
- Q92137696 P50 Q92137696-7D52C48F-B4F4-4BFE-8CBA-8DA3E8202C75 @default.
- Q92137696 P50 Q92137696-B4387005-159F-4CB4-9FE3-E4C6FAA4CBAD @default.
- Q92137696 P577 Q92137696-DA95621A-2E34-487E-972C-FC44093444F0 @default.
- Q92137696 P698 Q92137696-1D354ADA-012A-4B28-A195-EBCFD1E84875 @default.
- Q92137696 P921 Q92137696-03E779A5-B3E3-44FC-9BAD-992223EAB052 @default.
- Q92137696 P921 Q92137696-6B0E90B1-8F5B-4275-A4B4-303E1A422A09 @default.
- Q92137696 P356 S12185-019-02802-Y @default.
- Q92137696 P698 31858429 @default.
- Q92137696 P1433 Q6051416 @default.
- Q92137696 P1476 "Analysis of Japanese patients from the AUGMENT phase III study of lenalidomide + rituximab (R2) vs. rituximab + placebo in relapsed/refractory indolent non-Hodgkin lymphoma" @default.
- Q92137696 P2093 "Go Yamamoto" @default.
- Q92137696 P2093 "Hirokazu Nagai" @default.
- Q92137696 P2093 "Kensei Tobinai" @default.
- Q92137696 P2093 "Noriko Fukuhara" @default.